Item 2.02. Results of Operations and Financial Condition.
On August 5, 2021, BeiGene, Ltd. (the "Company") announced its financial results
for the three and six months ended June 30, 2021. A copy of the press release is
attached as Exhibit 99.1 to this Current Report on Form 8-K.
Item 8.01. Other Events.
In its press release dated August 5, 2021, the Company also provided an update
on the second quarter of 2021 and recent business highlights and expected
milestones for the remainder of 2021 and 2022. The information in the press
release set forth under the headings "Recent Business Highlights and Upcoming
Milestones" and "Forward-Looking Statements" is incorporated by reference into
this Item 8.01 of this Current Report on Form 8-K.
On August 3, 2021, the Company announced its plans to build a new campus for R&D
and manufacturing at the Princeton West Innovation Campus in Hopewell, NJ.
BeiGene has entered into a purchase agreement to acquire an approximately
42-acre site with over one million square feet of developable real estate, to
build a state-of-the-art facility that is expected to include commercial-stage
biologic pharmaceutical manufacturing, clinical R&D, and the BeiGene Center for
Pharmacovigilance Innovation. BeiGene intends to recruit hundreds of new hires
from the area's deep talent pool to support its continued growth and its
commitment to producing life-saving oncology medicines. The full text of this
press release is filed as Exhibit 99.2 to this Current Report on Form 8-K and is
incorporated herein by reference.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
Exhibit No.                                               Description
99.1                     Press release titled "BeiGene Reports Second

Quarter 2021 Financial Results",


                         issued by BeiGene, Ltd. on August 5, 2021.

99.2                     Press release titled "BeiGene Announces Plans to

Build New Manufacturing and


                         Clinical R&D Center at Princeton West Innovation Park in Hopewell, New
                         Jersey", issued by BeiGene, Ltd. on August 3, 2021.

104                      The cover page from this Current Report on Form

8-K, formatted in Inline XBRL

--------------------------------------------------------------------------------


                                 Exhibit Index

Exhibit No.              Description
99.1                       Press release titled "BeiGene Reports Second

Quarter 2021 Financial Results",


                         issued by BeiGene, Ltd. on August 5, 2021.

99.2                       Press release titled "BeiGene Announces Plans to

Build New Manufacturing and


                         Clinical R&D Center at Princeton West Innovation

Park in Hopewell, New Jersey",


                         issued by BeiGene, Ltd. on August 3, 2021.

104                      The cover page from this Current Report on Form 8-K, formatted in Inline XBRL

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses